Income Statement

v3.19.3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues $ 2,500 $ 2,500 $ 12,894 $ 257,500
Operating expenses:        
Research and development expenses 825,486 897,098 3,294,402 3,081,319
General and administrative expenses 1,301,189 1,188,076 3,217,613 3,630,822
Total operating expenses 2,126,675 2,085,174 6,512,015 6,712,141
Operating loss (2,124,175) (2,082,674) (6,499,121) (6,454,641)
Other income (expense):        
Interest income 15,234 17,619 55,086 54,882
Interest expense (1,913) (1,498) (4,437) (4,190)
Change in fair value of derivative instruments 320,785 236,270 416,796 1,805,319
Other income (expense) 26,935 (282,371) (5,667)
Total other income 361,041 252,391 185,074 1,850,344
Net loss $ (1,763,134) $ (1,830,283) $ (6,314,047) $ (4,604,297)
Net loss per share - basic and diluted (in dollars per share) $ (0.59) $ (2.41) $ (4.80) $ (6.08)
Weighted average common shares outstanding - basic and diluted (in shares) 2,975,779 758,575 1,316,597 757,221
Comprehensive loss:        
Net loss $ (1,763,134) $ (1,830,283) $ (6,314,047) $ (4,604,297)
Foreign currency translation adjustment (4,501) (512) (7,257) (2,001)
Comprehensive loss $ (1,767,635) $ (1,830,795) $ (6,321,304) $ (4,606,298)

Source